ARAS, M. Et Al. 2016. Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors. NUCLEAR MEDICINE COMMUNICATIONS , vol.37, no.1 , 9-15.

ARAS, M., ERDİL, T. Y., DANE, F., Gungor, S., ÖNEŞ, T., DEDE, F., ... İNANIR, S.(2016). Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors. NUCLEAR MEDICINE COMMUNICATIONS , vol.37, no.1, 9-15.

ARAS, MUSTAFA Et Al. "Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors," NUCLEAR MEDICINE COMMUNICATIONS , vol.37, no.1, 9-15, 2016

ARAS, MUSTAFA Et Al. "Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors." NUCLEAR MEDICINE COMMUNICATIONS , vol.37, no.1, pp.9-15, 2016

ARAS, M. Et Al. (2016) . "Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors." NUCLEAR MEDICINE COMMUNICATIONS , vol.37, no.1, pp.9-15.

@article{article, author={MUSTAFA ARAS Et Al. }, title={Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2016, pages={9-15} }